Shreekant Patil Moderator at Poland India Chamber Women Conference 2026, Leadership New Delhi

YouTube
Hanwha Ocean signed a technology transfer MOU with Ontario Shipyard and Mohawk College to bolster Canada's naval industry and prepare for future submarine contracts.
#YonhapInfomax #HanwhaOcean #OntarioShipyard #TechnologyTransfer #CanadianNavy #SubmarineProject #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=105835
Hanwha Ocean Signs Technology Transfer MOU with Ontario Shipyard to Prepare for Submarine Orders

Hanwha Ocean signed a technology transfer MOU with Ontario Shipyard and Mohawk College to bolster Canada's naval industry and prepare for future submarine contracts.

Yonhap Infomax

@tuga @woody Obviously mandating #TechnologyTransfer was a long-term strategy.

Heat Shield

Using cutting-edge material licensed from NASA, a protective heat shield manufactured in-house by Varda Space Industries for the first time enabled one of its

NASA
NASA Technology Brings Golden Age of Exploration to Earth - NASA

As NASA fosters technologies needed to live and work farther away from home than ever before, the agency’s Technology Transfer program has the sole mission of

NASA
D&D Pharmatech Co. revealed at the JP Morgan Healthcare Conference that it is in technology transfer talks with global pharmaceutical firms for DD01, its MASH therapy candidate, and plans to announce topline Phase 2 results in May.
#YonhapInfomax #DDPharmatech #DD01 #MASH #TechnologyTransfer #JPmorganHealthcareConference #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=100288
D&D Pharmatech in Talks for Technology Transfer of MASH Therapy Candidate DD01

D&D Pharmatech Co. revealed at the JP Morgan Healthcare Conference that it is in technology transfer talks with global pharmaceutical firms for DD01, its MASH therapy candidate, and plans to announce topline Phase 2 results in May.

Yonhap Infomax
Samjin Pharmaceutical is advancing the technology transfer of its chronic urticaria drug candidate SJN314, valued at 800 billion won ($610 million), with expectations for a share price revaluation and a strategic shift from generics to innovative drugs.
#YonhapInfomax
#SamjinPharmaceutical #SJN314 #TechnologyTransfer #ChronicUrticaria #ADCPlatform
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=100156
Samjin Pharmaceutical Pursues Technology Transfer Valued at 800 Billion Won—Shares Poised for Revaluation

Samjin Pharmaceutical is advancing the technology transfer of its chronic urticaria drug candidate SJN314, valued at 800 billion won ($610 million), with expectations for a share price revaluation and a strategic shift from generics to innovative drugs.

Yonhap Infomax

CMC đề xuất "mở không gian thị trường" để tạo điều kiện phát triển cho doanh nghiệp tư nhân. Đại diện CMC cho rằng khi doanh nghiệp có không gian phát triển đủ rộng, các chương trình khoa học công nghệ mới có thể được chuyển hóa thành năng suất, sản phẩm thực tế và góp phần nâng cao năng lực cạnh tranh quốc gia.

#CMC #DoanhNghiepTuNhan #PhatTrienKinhTe #KhoaHocCongNghe #ChinhSach #MarketExpansion #PrivateBusiness #VietnamEconomy #TechnologyTransfer #Competitiveness

https://vietnamnet.vn/cmc-de

Global pharmaceutical firms are paying upfront to secure technology transfer deals with Alteogen, as demand for its subcutaneous injection platform surges; Shinhan Investment maintains a 730,000 won target price, citing strong licensing prospects despite recent patent litigation.
#YonhapInfomax #Alteogen #TechnologyTransfer #ShinhanInvestment #OptionAgreement #TargetPrice730000Won #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=97468
Global Pharma Firms Pay to Get in Line for Alteogen’s Technology—Target Price Set at 730,000 Won

Global pharmaceutical firms are paying upfront to secure technology transfer deals with Alteogen, as demand for its subcutaneous injection platform surges; Shinhan Investment maintains a 730,000 won target price, citing strong licensing prospects despite recent patent litigation.

Yonhap Infomax

🚂 Nghị định 319 tạo bước ngoặt cho ngành đường sắt Việt Nam!
Lần đầu tiên đặt tiêu chí ưu tiên doanh nghiệp trong nước kết hợp chuyển giao công nghệ, thay thế phương thức nhập khẩu trọn gói. Cơ hội vàng để phát triển công nghiệp đường sắt nội địa! 🌟

#RailwayIndustry #VietnamPolicy #TechnologyTransfer
#DuongSatVietNam #NghiDinh319 #ChuyenGiaoCongNghe

https://vietnamnet.vn/nghi-dinh-319-dan-duong-cho-nganh-cong-nghiep-duong-sat-viet-nam-2472548.html

Nghị định 319 dẫn đường cho ngành công nghiệp đường sắt Việt Nam

Nghị định 319 lần đầu đặt tiêu chí lựa chọn DN Việt Nam gắn với chuyển giao công nghệ cho các dự án đường sắt, thay cho cách làm nhập khẩu trọn gói. Chính sách này mở ra cơ hội hiếm có hình thành và phát triển ngành công nghiệp đường sắt trong nước.

Vietnamnet.vn